Copenhagen, Denmark

Henrik Bjork Hansen

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignee: Saniona A/s. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henrik Bjork Hansen. Retrieved from https://idiyas.com/inventor/henrik-bjork-hansen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Henrik Bjork Hansen

Introduction

Henrik Bjork Hansen is a notable inventor based in Kobenhavn N, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in combination therapies. His work focuses on enhancing therapeutic efficacy while minimizing side effects.

Latest Patents

Henrik holds 1 patent for his invention titled "Pharmaceutical compositions for combination therapy." This invention relates to the use of pharmaceutical compositions that combine Tesofensine and Metoprolol. The goal is to prevent the cardiovascular side effects of Tesofensine while maintaining its effectiveness in reducing food intake and promoting body weight loss.

Career Highlights

Henrik is associated with Saniona A/S, a company dedicated to developing innovative treatments for various medical conditions. His role at Saniona has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Henrik has worked alongside talented colleagues such as Morten Grunnet and Bo Hjorth Bentzen. Their collaborative efforts have further advanced the research and development of effective pharmaceutical solutions.

Conclusion

Henrik Bjork Hansen's innovative work in pharmaceutical compositions exemplifies the importance of combining efficacy with safety in medical treatments. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…